(Q35821838)

10 August 2017

1 reference

title

Applicability of biomarkers in the early diagnosis of prostate cancer (English)

1 reference

10 August 2017

0 references

1 reference

Daphne Hessels

1

1 reference

10 August 2017

Gerald W Verhaegh

series ordinal

2

1 reference

10 August 2017

Jack A Schalken

series ordinal

3

1 reference

10 August 2017

J Alfred Witjes

series ordinal

4

1 reference

10 August 2017

publication date

1 July 2004

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

10 August 2017

published in

1 reference

10 August 2017

volume

4

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

513-526

1 reference

The case for early detection

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Proteomic analysis at the bedside: early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Prostate cancer biomarkers: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Evidence of an X-linked or recessive genetic component to prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Prostate cancer susceptibility genes: lessons learned and challenges posed

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Facile detection of mitochondrial DNA mutations in tumors and bodily fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

DNA alterations in body fluids as molecular tumor markers for urological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Human tissue kallikrein gene family: a rich source of novel disease biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Free prostate-specific antigen in serum is becoming more complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Quantitative analysis of kallikrein 15 gene expression in prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Diagnostic potential of serum proteomic patterns in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Environmental exposure, DNA methylation, and gene regulation: lessons from diethylstilbesterol-induced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Frequent hypermethylation of the RASSF1A gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

DNA-based detection of prostate cancer in urine after prostatic massage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Purification and characterization of an alpha-methylacyl-CoA racemase from human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.4.513

21 January 2018

Identifiers

DOI

10.1586/14737159.4.4.513

1 reference

10 August 2017

1 reference